Your browser doesn't support javascript.
loading
Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation.
da Silva, Michael Ruberson Ribeiro; Dos Santos, Jéssica Barreto Ribeiro; Almeida, Alessandra Maciel; Alvares-Teodoro, Juliana; Kakehasi, Adriana Maria; Acurcio, Francisco de Assis.
Afiliação
  • da Silva MRR; College of Pharmacy, Federal University of Minas Gerais, President Antônio Carlos Avenue, 6627, Campus Pampulha, Belo Horizonte, Minas Gerais, 31270-901, Brazil. mrubersonrs@gmail.com.
  • Dos Santos JBR; Department of Pharmacy and Nutrition, Federal University of Espírito Santo, Alto Universitário, s/nº - Guararema, Alegre, Espírito Santo, CEP 29500-000, Brazil. mrubersonrs@gmail.com.
  • Almeida AM; College of Pharmacy, Federal University of Minas Gerais, President Antônio Carlos Avenue, 6627, Campus Pampulha, Belo Horizonte, Minas Gerais, 31270-901, Brazil.
  • Alvares-Teodoro J; College of Pharmacy, Federal University of Minas Gerais, President Antônio Carlos Avenue, 6627, Campus Pampulha, Belo Horizonte, Minas Gerais, 31270-901, Brazil.
  • Kakehasi AM; College of Pharmacy, Federal University of Minas Gerais, President Antônio Carlos Avenue, 6627, Campus Pampulha, Belo Horizonte, Minas Gerais, 31270-901, Brazil.
  • Acurcio FA; Medicine School, Federal University of Minas Gerais, Alfredo Balena Avenue, 6627, Health Campus, Belo Horizonte, Minas Gerais, 30130-100, Brazil.
Adv Rheumatol ; 59(1): 48, 2019 11 14.
Article em En | MEDLINE | ID: mdl-31727164
BACKGROUND: Pharmaceutical Assistance (PA) is a dynamic and multidisciplinary process that aims to supply health systems, programs or services with quality medicines, enabling access and health care, in an efficient and timely manner. The objective of the study was to evaluate the profile of administrative processes for the treatment of PsA, identify the time elapsed in the flow of processes and its associated factors. METHODS: A cross-sectional study of medication requests for the treatment of PsA was carried out between November 2014 and December 2016. Linear regression was used to verify the factors associated with time to delivery. RESULTS: A total of 218 cases containing 250 drugs were analyzed. The median time between the medical appointment and the first dispensation was 66 days (interquartile range, 44-90). The State proceedings, which includes requesting the drug until the authorization of treatment, was the stage that most contributed to the total time spent. The factors associated with the longer time to delivery of medications were prescriptions coming from clinics and specialty centers, from dermatologists, non-authorized processes and non-persistent patients in the treatment in 12 months. CONCLUSION: The median time to receive medicines for the PsA treatment in Belo Horizonte health region after a medical prescription was higher than 2 months. The time between the solicitation of the medicines and the authorization of the treatment in the SUS (State administrative procedure) was the main component of the total time spent.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Custos de Medicamentos / Antirreumáticos / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Health_economic_evaluation / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Adv Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Custos de Medicamentos / Antirreumáticos / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Health_economic_evaluation / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Adv Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido